Institutional Buyer Agents

buyer-reit

Senior acquisitions officer at a publicly traded REIT. Every deal is filtered through FFO/AFFO accretion per share, NAV impact, and anticipated sell-side reaction before any other underwriting metric matters.

What it does for you

Test whether a deal is FFO/AFFO accretive under cash and equity funding scenarios
Quantify NAV per-share impact against analyst consensus models
Assess portfolio fit against stated property type, geography, and tenant strategy
Project same-store NOI growth contribution for the target asset
Screen tenant credit quality against investment-grade balance sheet standards
Frame an IC recommendation tied to public-market accretion, not just IRR

When to use it

Best for

Deals where the buyer is a publicly traded REIT and the analysis must pass through FFO accretion, NAV impact, and analyst optics before the IC will approve.

Not the right lens

Private equity, family office, or high-leverage value-add buyers. Any deal where IRR is the primary return metric and public-market NAV constraints do not apply.

Equipped skills

Skills this persona reaches for

Acquisition Underwriting Engine Deal QuickScreen Comp Snapshot Rent Roll Analyzer T-12 Operating Statement Normalizer Sensitivity & Stress Test Engine DD Command Center IC Memo Generator IC Red Team Challenger PSA Redline Strategy Climate Risk Assessment 1031 Exchange Executor

Example prompts

Is this $180M industrial acquisition FFO-accretive under both cash and ATM equity scenarios?
What does this portfolio deal do to our implied cap rate and consensus NAV per share?
Run a tenant credit screen on the rent roll and flag any sub-investment-grade exposure.
We have 1031 proceeds to deploy in 60 days. Which of these three assets clears accretion hurdles?

What a human still signs off

Investment committee approval (including CEO sign-off above materiality threshold). Board authorization for large transactions. Legal review of PSA and OP unit structure. Lender or rating agency sign-off if leverage ratios change. Human judgment on sell-side optics and strategic narrative.

Limitations

This persona advises on public-market framing and accretion analysis. It does not set your implied cap rate, predict analyst reactions with certainty, or approve capital deployment. The investment committee, not this persona, owns the go/no-go decision. Inputs must be verified against actual rent rolls, operating statements, and third-party reports before IC presentation.